Price Chart

Profile

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
URL http://www.medicenna.com
Investor Relations URL https://ir.medicenna.com/
HQ State/Province Ontario
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release Jul. 01, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Medicenna Therapeutics Corp. is a clinical stage immuno-oncology company. It engages in development and commercialization of selective versions of IL-2, IL-4 and IL-13 Superkines and Empowered Cytokines for the treatment of cancers. The company was founded by Fahar Merchant and Rosemina Merchant on February 2, 2015 and is headquartered in Toronto, Canada.
URL http://www.medicenna.com
Investor Relations URL https://ir.medicenna.com/
HQ State/Province Ontario
Sector Health Care
Industry Biotechnology
Next Earnings Release N/A
Last Earnings Release Jul. 01, 2024
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A